-
1
-
-
0003734119
-
-
London: Mosby
-
Allison, MC; Dhillon, AP; Lewis, WG; Pounder, RE. Inflammatory Bowel Disease. London: Mosby, 1998, 9-95.
-
(1998)
Inflammatory Bowel Disease
, pp. 9-95
-
-
Allison, M.C.1
Dhillon, A.P.2
Lewis, W.G.3
Pounder, R.E.4
-
2
-
-
0037043658
-
Inflammatory bowel disease
-
Podolsky, DK. Inflammatory bowel disease. N Engl J Med, 2002, 347, 417-429.
-
(2002)
N Engl J Med
, vol.347
, pp. 417-429
-
-
Podolsky, D.K.1
-
3
-
-
0024404284
-
Dietary antigens as aggravating factors in Crohn’s disease
-
Harris, ML; Bayless, TM. Dietary antigens as aggravating factors in Crohn’s disease. Dig Dis Sci, 1989, 34, 1613-1614.
-
(1989)
Dig Dis Sci
, vol.34
, pp. 1613-1614
-
-
Harris, M.L.1
Bayless, T.M.2
-
4
-
-
0021894149
-
Inflammatory bowel disease at the University of Chicago-the first 50 years: Some personal reflections
-
Kirsner, JB. Inflammatory bowel disease at the University of Chicago-the first 50 years: some personal reflections. Am J Gastroenterol, 1985, 80, 219-226.
-
(1985)
Am J Gastroenterol
, vol.80
, pp. 219-226
-
-
Kirsner, J.B.1
-
5
-
-
0015334062
-
Inflammatory colon disease in Rochester, Minnnesota, 1935-1964
-
Sedlack, RE; Nobrega, FT; Kurland, LT; Sauer, WG. Inflammatory colon disease in Rochester, Minnnesota, 1935-1964. Gastroenterology, 1972, 62, 935-941.
-
(1972)
Gastroenterology
, vol.62
, pp. 935-941
-
-
Sedlack, R.E.1
Nobrega, F.T.2
Kurland, L.T.3
Sauer, W.G.4
-
6
-
-
2442713756
-
Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988-1999)
-
Molinie, F; Gower-Rousseau, C; Yzet, T; Merle, V; Grandbastien, B; Marti, R; Lerebours, E; Dupas, JL; Colombel, JF; Salomez, JL; Cortot A. Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988-1999). Gut 2004, 53, 843-848.
-
(2004)
Gut
, vol.53
, pp. 843-848
-
-
Molinie, F.1
Gower-Rousseau, C.2
Yzet, T.3
Merle, V.4
Grandbastien, B.5
Marti, R.6
Lerebours, E.7
Dupas, J.L.8
Colombel, J.F.9
Salomez, J.L.10
Cortot, A.11
-
7
-
-
33750609696
-
Recent trends in the epidemiology of inflammatory bowel diseases: Up or down?
-
Lakatos, PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol, 2006, 12, 6102-6108.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 6102-6108
-
-
Lakatos, P.L.1
-
8
-
-
0033784182
-
Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997
-
Yang, SK; Hong, WS; Min, YI; Kim, HY; Yoo, JY; Rhee, PL; Rhee, JC; Chang, DK; Song, IS; Jung, SA; Park, EB; Yoo, HM; Lee, DK; Kim, YK. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol, 2000, 15, 1037-1042.
-
(2000)
J Gastroenterol Hepatol
, vol.15
, pp. 1037-1042
-
-
Yang, S.K.1
Hong, W.S.2
Min, Y.I.3
Kim, H.Y.4
Yoo, J.Y.5
Rhee, P.L.6
Rhee, J.C.7
Chang, D.K.8
Song, I.S.9
Jung, S.A.10
Park, E.B.11
Yoo, H.M.12
Lee, D.K.13
Kim, Y.K.14
-
9
-
-
0037022008
-
Crohn’s disease
-
Shanahan, F. Crohn’s disease. Lancet, 2002, 359, 62-69.
-
(2002)
Lancet
, vol.359
, pp. 62-69
-
-
Shanahan, F.1
-
10
-
-
21844439780
-
The emergence of inflammatory bowel disease in the Asian Pacific region
-
Ouyang, Q; Tandon, R; Goh, KL; Ooi, CJ; Ogata, H; Fiocchi, C. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol, 2005, 21, 408-413.
-
(2005)
Curr Opin Gastroenterol
, vol.21
, pp. 408-413
-
-
Ouyang, Q.1
Tandon, R.2
Goh, K.L.3
Ooi, C.J.4
Ogata, H.5
Fiocchi, C.6
-
11
-
-
33644826707
-
Crohn’s disease in mainland China: A systematic analysis of 50 years of research
-
Zheng, JJ; Zhu, XS; Huangfu, Z; Gao, ZX; Guo, ZR; Wang, Z. Crohn’s disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis, 2005, 6, 175-181.
-
(2005)
Chin J Dig Dis
, vol.6
, pp. 175-181
-
-
Zheng, J.J.1
Zhu, X.S.2
Huangfu, Z.3
Gao, Z.X.4
Guo, Z.R.5
Wang, Z.6
-
12
-
-
34249827613
-
Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?
-
Asakura, H; Suzuki, K; Honma, T. Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?. World J Gastroenterol, 2007, 13, 2145-2149.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 2145-2149
-
-
Asakura, H.1
Suzuki, K.2
Honma, T.3
-
13
-
-
0030830553
-
Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases
-
Sartor, RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol, 1997, 92, 5S-11S.
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 5S-11S
-
-
Sartor, R.B.1
-
14
-
-
0020964483
-
Sulfasalazine. Adverse effects and desensitization
-
Taffet, SL; Das, KM. Sulfasalazine. Adverse effects and desensitization. Dig Dis Sci, 1983, 28, 833-842.
-
(1983)
Dig Dis Sci
, vol.28
, pp. 833-842
-
-
Taffet, S.L.1
Das, K.M.2
-
15
-
-
0034132356
-
How to do without steroids in inflammatory bowel disease
-
Present, DH. How to do without steroids in inflammatory bowel disease. Inflamm Bowel Dis, 2000, 6, 48-57.
-
(2000)
Inflamm Bowel Dis
, vol.6
, pp. 48-57
-
-
Present, D.H.1
-
16
-
-
0024587677
-
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial
-
Rachmilewitz, D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ, 1989, 298, 82-86.
-
(1989)
BMJ
, vol.298
, pp. 82-86
-
-
Rachmilewitz, D.1
-
17
-
-
2442526434
-
Medical therapy for ulcerative colitis 2004
-
Hanauer, SB. Medical therapy for ulcerative colitis 2004. Gastroenterology, 2004, 126, 1582-1592.
-
(2004)
Gastroenterology
, vol.126
, pp. 1582-1592
-
-
Hanauer, S.B.1
-
18
-
-
0029013896
-
How effective is current medical therapy for severe ulcerative and Crohn’s colitis? An analytic review of selected trials
-
Kornbluth, A; Marion, JF; Salomon, P; Janowitz, HD. How effective is current medical therapy for severe ulcerative and Crohn’s colitis? An analytic review of selected trials. J Clin Gastroenterol, 1995, 20, 280-284.
-
(1995)
J Clin Gastroenterol
, vol.20
, pp. 280-284
-
-
Kornbluth, A.1
Marion, J.F.2
Salomon, P.3
Janowitz, H.D.4
-
19
-
-
0031776748
-
Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: Time for a reappraisal?
-
Hyde, GM; Thillainayagam, AV; Jewell DP. Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? Eur J Gastroenterol Hepatol, 1998, 10, 411-413.
-
(1998)
Eur J Gastroenterol Hepatol
, vol.10
, pp. 411-413
-
-
Hyde, G.M.1
Thillainayagam, A.V.2
Jewell, D.P.3
-
20
-
-
1842689546
-
Can cyclosporine go it alone in severe ulcerative colitis?
-
Hanauer, SB. Can cyclosporine go it alone in severe ulcerative colitis? Curr Gastroenterol Rep, 2001, 3, 455-456.
-
(2001)
Curr Gastroenterol Rep
, vol.3
, pp. 455-456
-
-
Hanauer, S.B.1
-
21
-
-
2342560435
-
Biochemical mechanisms of cyclosporine neurotoxicity
-
Serkova, NJ; Christians, U; Benet, LZ. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv, 2004, 4, 97-107.
-
(2004)
Mol Interv
, vol.4
, pp. 97-107
-
-
Serkova, N.J.1
Christians, U.2
Benet, L.Z.3
-
22
-
-
0033528272
-
Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn’s disease
-
Schreiber, S; Nikolaus, S; Hampe, J; Hamling, J; Koop, I; Groessner, B; Lochs, H; Raedler A. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn’s disease. Lancet, 1999, 353, 459-461.
-
(1999)
Lancet
, vol.353
, pp. 459-461
-
-
Schreiber, S.1
Nikolaus, S.2
Hampe, J.3
Hamling, J.4
Koop, I.5
Groessner, B.6
Lochs, H.7
Raedler, A.8
-
23
-
-
0034005581
-
Role of cytokines in the pathogenesis of inflammatory bowel disease
-
Papadakis, KA; Targan, SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med, 2000, 51, 289-298.
-
(2000)
Annu Rev Med
, vol.51
, pp. 289-298
-
-
Papadakis, K.A.1
Targan, S.R.2
-
24
-
-
0030954732
-
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group
-
Targan, SR; Hanauer, SB; van Deventer, SJ; Mayer, L; Present, DH; Braakman, T; DeWoody, KL; Schaible, TF; Rutgeerts, PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med, 1997, 337, 1029-1035.
-
(1997)
N Engl J Med
, vol.337
, pp. 1029-1035
-
-
Targan, S.R.1
Hanauer, S.B.2
van Deventer, S.J.3
Mayer, L.4
Present, D.H.5
Braakman, T.6
DeWoody, K.L.7
Schaible, T.F.8
Rutgeerts, P.J.9
-
25
-
-
0037018761
-
Maintenance infliximab for Crohn’s disease: The ACCENT I randomised trial
-
Hanauer, SB; Feagan, BG; Lichtenstein, GR; Mayer, LF; Schreiber, S; Colombel, JF; Rachmilewitz, D; Wolf, DC; Olson, A; Bao, W; Rutgeerts, P. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet, 2002, 359, 1541-1549.
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
Rachmilewitz, D.7
Wolf, D.C.8
Olson, A.9
Bao, W.10
Rutgeerts, P.11
-
26
-
-
28844473957
-
Infliximab for induction and maintenance therapy for ulcerative colitis
-
Rutgeerts, P; Sandborn, WJ; Feagan, BG; Reinisch, W; Olson, A; Johanns, J; Travers, S; Rachmilewitz, D; Hanauer, SB; Lichtenstein, GR; de Villiers, WJ; Present, D; Sands, BE; Colombel, JF. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med, 2005, 353, 2462-2476.
-
(2005)
N Engl J Med
, vol.353
, pp. 2462-2476
-
-
Rutgeerts, P.1
Sandborn, W.J.2
Feagan, B.G.3
Reinisch, W.4
Olson, A.5
Johanns, J.6
Travers, S.7
Rachmilewitz, D.8
Hanauer, S.B.9
Lichtenstein, G.R.10
de Villiers, W.J.11
Present, D.12
Sands, B.E.13
Colombel, J.F.14
-
27
-
-
20444487429
-
Infliximab induction and maintenance therapy for ulcerative colitis: The ACT2 trial
-
Sandborn, WJ; Rachmilewitz, D; Hanauer, SB. Infliximab induction and maintenance therapy for ulcerative colitis: the ACT2 trial. Gastroenterology, 2005, 128, A36.
-
(2005)
Gastroenterology
, vol.128
, pp. A36
-
-
Sandborn, W.J.1
Rachmilewitz, D.2
Hanauer, S.B.3
-
28
-
-
0037640033
-
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy
-
Devos, SA; Van Den Bossche, N; De Vos, M; Naeyaert, JM. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology, 2003, 206, 388-390.
-
(2003)
Dermatology
, vol.206
, pp. 388-390
-
-
Devos, S.A.1
Van Den Bossche, N.2
De Vos, M.3
Naeyaert, J.M.4
-
29
-
-
0036272256
-
Review article: A critical approach to new forms of treatment of Crohn’s disease and ulcerative colitis
-
Seegers, D; Bouma, G; Pena, AS. Review article: a critical approach to new forms of treatment of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther, 2002, 16 Suppl, 4, 53-58.
-
(2002)
Aliment Pharmacol Ther
, vol.4
, Issue.16
, pp. 53-58
-
-
Seegers, D.1
Bouma, G.2
Pena, A.S.3
-
30
-
-
0041653315
-
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report
-
Gomez-Reino, JJ; Carmona, L; Valverde, VR; Mola, EM; Montero, MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum, 2003, 48, 2122-2127.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2122-2127
-
-
Gomez-Reino, J.J.1
Carmona, L.2
Valverde, V.R.3
Mola, E.M.4
Montero, M.D.5
-
31
-
-
0042027086
-
Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy
-
(Oxford)
-
Kroesen, S; Widmer, AF; Tyndall, A; Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford), 2003, 42, 617-621.
-
(2003)
Rheumatology
, vol.42
, pp. 617-621
-
-
Kroesen, S.1
Widmer, A.F.2
Tyndall, A.3
Hasler, P.4
-
32
-
-
0036900501
-
Tumor necrosis factor antagonist therapy and lymphoma development, twenty-six cases reported to the Food and Drug Administration
-
Brown, SL; Greene, MH; Gershon, SK; Edwards, ET; Braun, MM. Tumor necrosis factor antagonist therapy and lymphoma development, twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum, 2002, 46, 3151-3158.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 3151-3158
-
-
Brown, S.L.1
Greene, M.H.2
Gershon, S.K.3
Edwards, E.T.4
Braun, M.M.5
-
33
-
-
24344450107
-
Autoantibody profile during short-term infliximab treatment for Crohn’s disease: A prospective cohort study
-
Atzeni, F; Ardizzone, S; Sarzi-Puttini, P; Colombo, E; Maconi, G; De Portu, S; Carrabba, M; Bianchi Porro, G. Autoantibody profile during short-term infliximab treatment for Crohn’s disease: a prospective cohort study. Aliment Pharmacol Ther, 2005, 22, 453-461.
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 453-461
-
-
Atzeni, F.1
Ardizzone, S.2
Sarzi-Puttini, P.3
Colombo, E.4
Maconi, G.5
De Portu, S.6
Carrabba, M.7
Bianchi Porro, G.8
-
34
-
-
33646696885
-
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
-
Bongartz, T; Sutton, AJ; Sweeting, MJ; Buchan, I; Matteson, EL; Montori, V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA, 2006, 295, 2275-2285.
-
(2006)
JAMA
, vol.295
, pp. 2275-2285
-
-
Bongartz, T.1
Sutton, A.J.2
Sweeting, M.J.3
Buchan, I.4
Matteson, E.L.5
Montori, V.6
-
35
-
-
33747143080
-
Anorectal carcinoma after infliximab therapy in Crohn’s disease: Report of a case
-
Melichar, B; Bures, J; Dedic, K. Anorectal carcinoma after infliximab therapy in Crohn’s disease: report of a case. Dis Colon Rectum, 2006, 49, 1228-1233.
-
(2006)
Dis Colon Rectum
, vol.49
, pp. 1228-1233
-
-
Melichar, B.1
Bures, J.2
Dedic, K.3
-
36
-
-
0028894398
-
The production of cytokines by polymorphonuclear neutrophils
-
Cassatella, MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today, 1995, 16, 21-26.
-
(1995)
Immunol Today
, vol.16
, pp. 21-26
-
-
Cassatella, M.A.1
-
37
-
-
0031903013
-
Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation
-
Nikolaus, S; Bauditz, J; Gionchetti, P; Witt, C; Lochs, H; Schreiber, S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut, 1998, 42, 470-476.
-
(1998)
Gut
, vol.42
, pp. 470-476
-
-
Nikolaus, S.1
Bauditz, J.2
Gionchetti, P.3
Witt, C.4
Lochs, H.5
Schreiber, S.6
-
38
-
-
33645367812
-
Lack of association between the promoter polymorphism in the human CCL5/RANTES chemokine gene on liver transplant outcome
-
Botella, C; Marín, L; Moya-Quiles, MR; Miras, M; Sánchez-Bueno, F; Minguela, A; Robles, R; Bermejo, J; Parrilla, P; Álvarez-López, R, Muro M. Lack of association between the promoter polymorphism in the human CCL5/RANTES chemokine gene on liver transplant outcome. Transplant Int, 2006, 19, 98-104.
-
(2006)
Transplant Int
, vol.19
, pp. 98-104
-
-
Botella, C.1
Marín, L.2
Moya-Quiles, M.R.3
Miras, M.4
Sánchez-Bueno, F.5
Minguela, A.6
Robles, R.7
Bermejo, J.8
Parrilla, P.9
Álvarez-López, R.10
Muro, M.11
-
39
-
-
0033062427
-
Implication of soluble and membrane HLA class-I and serum IL-10 in liver graft acceptance
-
Minguela, A; Torío, A; Marin, L; Muro, M; Villar, LM; Pons, JA; Diaz, J; Parrilla, P; García-Alonso, AM; Álvarez-López, MR. Implication of soluble and membrane HLA class-I and serum IL-10 in liver graft acceptance. Human Immunol, 1999, 60, 500-509.
-
(1999)
Human Immunol
, vol.60
, pp. 500-509
-
-
Minguela, A.1
Torío, A.2
Marin, L.3
Muro, M.4
Villar, L.M.5
Pons, J.A.6
Diaz, J.7
Parrilla, P.8
García-Alonso, A.M.9
Álvarez-López, M.R.10
-
40
-
-
34250823471
-
TGF-beta1 gene polymorphism in liver graft recipients
-
Gómez-Mateo, J; Marin, L; López-Alvarez, MR; Moya-Quiles, MR; Miras, M; Marin-Moreno, I; Botella, C; Parrilla, P; Álvarez-López, MR; Muro, M. TGF-beta1 gene polymorphism in liver graft recipients. Transplant Immunol, 2006, 17, 55-59.
-
(2006)
Transplant Immunol
, vol.17
, pp. 55-59
-
-
Gómez-Mateo, J.1
Marin, L.2
López-Alvarez, M.R.3
Moya-Quiles, M.R.4
Miras, M.5
Marin-Moreno, I.6
Botella, C.7
Parrilla, P.8
Álvarez-López, M.R.9
Muro, M.10
-
41
-
-
37849049256
-
CCL5/RANTES chemokine polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population
-
Muro, M; Marin, L; Torio, A; Pagan, JA; Álvarez-López, MR. CCL5/RANTES chemokine polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Int J Immunogenetics, 2008, 35, 19-23.
-
(2008)
Int J Immunogenetics
, vol.35
, pp. 19-23
-
-
Muro, M.1
Marin, L.2
Torio, A.3
Pagan, J.A.4
-
42
-
-
0034234796
-
Surrogate markers of intestinal infl ammation are predictive of relapse in patients with inflammatory bowel disease
-
Tibble, JA; Sigthorsson, G; Bridger, S; Fagerhol, MK; Bjarnason, I. Surrogate markers of intestinal infl ammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology, 2000, 119, 15-22.
-
(2000)
Gastroenterology
, vol.119
, pp. 15-22
-
-
Tibble, J.A.1
Sigthorsson, G.2
Bridger, S.3
Fagerhol, M.K.4
Bjarnason, I.5
-
43
-
-
0033784967
-
Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy
-
Limburg, PJ; Ahlquist, DA; Sandborn, WJ; Mahoney, DW; Devens, ME; Harrington, JJ; Zinsmeister, AR. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol, 2000, 95, 2831-2837.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 2831-2837
-
-
Limburg, P.J.1
Ahlquist, D.A.2
Sandborn, W.J.3
Mahoney, D.W.4
Devens, M.E.5
Harrington, J.J.6
Zinsmeister, A.R.7
-
44
-
-
0033013167
-
Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease
-
Roseth, AG; Schmidt, PN; Fagerhol, MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol, 1999, 34, 50-54.
-
(1999)
Scand J Gastroenterol
, vol.34
, pp. 50-54
-
-
Roseth, A.G.1
Schmidt, P.N.2
Fagerhol, M.K.3
-
45
-
-
0025721860
-
Peripheral blood neutrophils in inflammatory bowel disease: Morphological evidence of in vivo activation in active disease
-
McCarthy, DA; Rampton, DS; Liu, YC. Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol, 1991, 86, 489-493.
-
(1991)
Clin Exp Immunol
, vol.86
, pp. 489-493
-
-
McCarthy, D.A.1
Rampton, D.S.2
Liu, Y.C.3
-
46
-
-
0034133163
-
The key role of macrophages in the immunopathogenesis of inflammatory bowel disease
-
Mahida, YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis, 2000, 6, 21-33.
-
(2000)
Inflamm Bowel Dis
, vol.6
, pp. 21-33
-
-
Mahida, Y.R.1
-
47
-
-
0036797131
-
Therapeutic effi cacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis
-
Hanai, H; Watanabe, F; Saniabadi, AR; Matsushitai, I; Takeuchi, K; Iida, T. Therapeutic effi cacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci, 2002, 47, 2349-2353.
-
(2002)
Dig Dis Sci
, vol.47
, pp. 2349-2353
-
-
Hanai, H.1
Watanabe, F.2
Saniabadi, A.R.3
Matsushitai, I.4
Takeuchi, K.5
Iida, T.6
-
48
-
-
10744219963
-
Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective, uncontrolled, pilot study
-
Hanai, H; Watanabe, F; Takeuchi, K; Iida, T; Yamada, M; Iwaoka, Y; Saniabadi, A; Matsushita, I; Sato, Y; Tozawa, K; Arai, H; Furuta, T; Sugimoto, K; Bjarnason, I. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol, 2003, 1, 28-35.
-
(2003)
Clin Gastroenterol Hepatol
, vol.1
, pp. 28-35
-
-
Hanai, H.1
Watanabe, F.2
Takeuchi, K.3
Iida, T.4
Yamada, M.5
Iwaoka, Y.6
Saniabadi, A.7
Matsushita, I.8
Sato, Y.9
Tozawa, K.10
Arai, H.11
Furuta, T.12
Sugimoto, K.13
Bjarnason, I.14
-
49
-
-
0038779569
-
Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes
-
Saniabadi, AR; Hanai, H; Takeuchi, K; Umemura, K; Nakashima, M; Adachi, T, Shima, C; Bjarnason, I; Lofberg, R. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial, 2003, 7, 48-59.
-
(2003)
Ther Apher Dial
, vol.7
, pp. 48-59
-
-
Saniabadi, A.R.1
Hanai, H.2
Takeuchi, K.3
Umemura, K.4
Nakashima, M.5
Adachi, T.6
Shima, C.7
Bjarnason, I.8
Lofberg, R.9
-
50
-
-
0028240846
-
Increased macrophage subset in inflammatory bowel disease: Apparent recruitment from peripheral blood monocytes
-
Rugtveit, J; Brandtzaeg, P; Halstensen, TS; Fausa, O; Scott, H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut, 1994, 35, 669-674.
-
(1994)
Gut
, vol.35
, pp. 669-674
-
-
Rugtveit, J.1
Brandtzaeg, P.2
Halstensen, T.S.3
Fausa, O.4
Scott, H.5
-
51
-
-
0018140011
-
Macrophage turnover in Crohn’s disease and ulcerative colitis
-
Meuret, G; Bitzi, A; Hammer, B. Macrophage turnover in Crohn’s disease and ulcerative colitis. Gastroenterology, 1978, 74, 501-503.
-
(1978)
Gastroenterology
, vol.74
, pp. 501-503
-
-
Meuret, G.1
Bitzi, A.2
Hammer, B.3
-
52
-
-
0034182004
-
Neutrophil apoptosis is delayed in patients with infl ammatory bowel disease
-
Brannigan, AE; O’Connell, PR; Hurley, H; O’Neill, A; Brady, HR; Fitzpatrick, JM; Watson, RW. Neutrophil apoptosis is delayed in patients with infl ammatory bowel disease. Shock, 2000, 13, 361-366.
-
(2000)
Shock
, vol.13
, pp. 361-366
-
-
Brannigan, A.E.1
O’Connell, P.R.2
Hurley, H.3
O’Neill, A.4
Brady, H.R.5
Fitzpatrick, J.M.6
Watson, R.W.7
-
53
-
-
0029972142
-
Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
-
Meagher, LC; Cousin, JM; Seckl, JR; Haslett, C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol, 1996,156, 4422-4428.
-
(1996)
J Immunol
, vol.156
, pp. 4422-4428
-
-
Meagher, L.C.1
Cousin, J.M.2
Seckl, J.R.3
Haslett, C.4
-
54
-
-
0027484754
-
Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators
-
Lee, A; Whyte, MK; Haslett, C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol, 1993, 54, 283-288.
-
(1993)
J Leukoc Biol
, vol.54
, pp. 283-288
-
-
Lee, A.1
Whyte, M.K.2
Haslett, C.3
-
55
-
-
23344431535
-
Defects in mucosal immunity leading to Crohn’s disease
-
Cobrin, GM; Abreu, MT. Defects in mucosal immunity leading to Crohn’s disease. Immunol Rev, 2005, 206, 277-295.
-
(2005)
Immunol Rev
, vol.206
, pp. 277-295
-
-
Cobrin, G.M.1
Abreu, M.T.2
-
56
-
-
0037380969
-
CARD15/NOD2 functionsas an antibacterial factor in human intestinal epithelial cells
-
Hisamatsu, T; Suzuki, M; Reinecker, HC; Nadeau, WJ; McCormick, BA; Podolsky, DK. CARD15/NOD2 functionsas an antibacterial factor in human intestinal epithelial cells. Gastroenterology, 2003, 124, 993-1000.
-
(2003)
Gastroenterology
, vol.124
, pp. 993-1000
-
-
Hisamatsu, T.1
Suzuki, M.2
Reinecker, H.C.3
Nadeau, W.J.4
McCormick, B.A.5
Podolsky, D.K.6
-
57
-
-
0142249896
-
Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology
-
Timmer, A. Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology. Dig Dis, 2003, 21, 91-104.
-
(2003)
Dig Dis
, vol.21
, pp. 91-104
-
-
Timmer, A.1
-
58
-
-
0041927822
-
Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning
-
Zheng, CQ; Hu, GZ; Zeng, ZS; Lin, LJ; Gu, GG. Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning. World J Gastroenterol, 2003, 9, 1646-1656.
-
(2003)
World J Gastroenterol
, vol.9
, pp. 1646-1656
-
-
Zheng, C.Q.1
Hu, G.Z.2
Zeng, Z.S.3
Lin, L.J.4
Gu, G.G.5
-
59
-
-
21844432979
-
Nucleotide-binding-oligomerization domain proteins and toll-like receptors: Sensors of the inflammatory bowel diseases’ microbial environment
-
Mueller, T; Podolsky, DK. Nucleotide-binding-oligomerization domain proteins and toll-like receptors: sensors of the inflammatory bowel diseases’ microbial environment. Curr Opin Gastroenterol, 2005, 21, 419-425.
-
(2005)
Curr Opin Gastroenterol
, vol.21
, pp. 419-425
-
-
Mueller, T.1
Podolsky, D.K.2
-
60
-
-
21344474630
-
Human defensins in Crohn’s disease
-
Wehkamp, J; Fellermann, K; Stange, EF. Human defensins in Crohn’s disease. Chem Immunol Allergy, 2005, 86, 41-54.
-
(2005)
Chem Immunol Allergy
, vol.86
, pp. 41-54
-
-
Wehkamp, J.1
Fellermann, K.2
Stange, E.F.3
-
61
-
-
0033000343
-
IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation
-
Schultz, M; Tonkonogy, SL; Sellon, RK; Veltkamp, C; Godfrey, VL; Kwon, J; Grenther, WB; Balish, E; Horak, I; Sartor, RB. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol, 1999, 276, G1461-G1472.
-
(1999)
Am J Physiol
, vol.276
, pp. G1461-G1472
-
-
Schultz, M.1
Tonkonogy, S.L.2
Sellon, R.K.3
Veltkamp, C.4
Godfrey, V.L.5
Kwon, J.6
Grenther, W.B.7
Balish, E.8
Horak, I.9
Sartor, R.B.10
-
62
-
-
22744438084
-
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis
-
Bibiloni, R; Fedorak, RN; Tannock, GW; Madsen, KL; Gionchetti, P; Campieri, M; De Simone, C; Sartor, RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol, 2005, 100, 1539-1546.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1539-1546
-
-
Bibiloni, R.1
Fedorak, R.N.2
Tannock, G.W.3
Madsen, K.L.4
Gionchetti, P.5
Campieri, M.6
De Simone, C.7
Sartor, R.B.8
-
63
-
-
2342646956
-
Bacterial flagellin is a dominant antigen in Crohn disease
-
Lodes, MJ; Cong, Y; Elson, CO; Mohamath, R; Landers, CJ; Targan, SR; Fort, M; Hershberg, RM. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004, 113, 1296-1306.
-
(2004)
J Clin Invest
, vol.113
, pp. 1296-1306
-
-
Lodes, M.J.1
Cong, Y.2
Elson, C.O.3
Mohamath, R.4
Landers, C.J.5
Targan, S.R.6
Fort, M.7
Hershberg, R.M.8
-
64
-
-
33750228901
-
Probiotics and prebiotics in chronic inflammatory bowel diseases
-
Ewaschuk, JB; Dieleman, LA. Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol, 2006, 12, 5941-5950.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 5941-5950
-
-
Ewaschuk, J.B.1
Dieleman, L.A.2
-
65
-
-
33744984785
-
Th17: An effector CD4 T cell lineage with regulatory T cell ties
-
Weaver, CT; Harrington, LE; Mangan, PR; Gavrieli, M; Murphy, KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity, 2006, 24, 677-688.
-
(2006)
Immunity
, vol.24
, pp. 677-688
-
-
Weaver, C.T.1
Harrington, L.E.2
Mangan, P.R.3
Gavrieli, M.4
Murphy, K.M.5
-
66
-
-
27744437941
-
Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria
-
Kamada, N; Hisamatsu, T; Okamoto, S; Sato, T; Matsuoka, K; Arai, K; Nakai, T; Hasegawa, A; Inoue, N; Watanabe, N; Akagawa, KS; Hibi, T. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol, 2005, 175, 6900-6908.
-
(2005)
J Immunol
, vol.175
, pp. 6900-6908
-
-
Kamada, N.1
Hisamatsu, T.2
Okamoto, S.3
Sato, T.4
Matsuoka, K.5
Arai, K.6
Nakai, T.7
Hasegawa, A.8
Inoue, N.9
Watanabe, N.10
Akagawa, K.S.11
Hibi, T.12
-
67
-
-
23344446340
-
Defects in mucosal immunity leading to ulcerative colitis
-
Targan, SR; Karp, LC. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev, 2005, 206, 296-305.
-
(2005)
Immunol Rev
, vol.206
, pp. 296-305
-
-
Targan, S.R.1
Karp, L.C.2
-
68
-
-
0344653641
-
HLA-DRB1 and-DQB1 polymorphism in liver recipients: Relationship between HLA-DQB1*0302 allele frequency and acute rejection
-
Muro, M; Álvarez-López, MR; Torío, A; Ontañón, J; Minguela, A; Marín, L; GarcíaCalatayud, MC; Bermejo, J; García-Alonso, AM. HLA-DRB1 and-DQB1 polymorphism in liver recipients: relationship between HLA-DQB1*0302 allele frequency and acute rejection. Human Immunol, 1997, 56, 70-76.
-
(1997)
Human Immunol
, vol.56
, pp. 70-76
-
-
Muro, M.1
Álvarez-López, M.R.2
Torío, A.3
Ontañón, J.4
Minguela, A.5
Marín, L.6
GarcíaCalatayud, M.C.7
Bermejo, J.8
García-Alonso, A.M.9
-
69
-
-
0035544343
-
Polymorphism in the upstream regulatory region of the HLA-DQB1 gene in liver graft recipients
-
Muro, M; Herrero, N; Marín, L; Torío, A; Minguela, A; Sánchez-Bueno, F; García-Alonso, AM; Álvarez-López, MR. Polymorphism in the upstream regulatory region of the HLA-DQB1 gene in liver graft recipients. Human Biol, 2001, 73, 845-854.
-
(2001)
Human Biol
, vol.73
, pp. 845-854
-
-
Muro, M.1
Herrero, N.2
Marín, L.3
Torío, A.4
Minguela, A.5
Sánchez-Bueno, F.6
García-Alonso, A.M.7
Álvarez-López, M.R.8
-
70
-
-
0042983850
-
Effect of partial HLA-Class I match on acute rejection in viral preinfected human liver allograft recipients
-
Ontañón, J; Muro, M; García-Alonso, AM; Minguela, A; Torio, A; Bermejo, J; Pons, JA; Campos, M; Álvarez-López, MR. Effect of partial HLA-Class I match on acute rejection in viral preinfected human liver allograft recipients. Transplantation, 1998, 65, 1047-1053.
-
(1998)
Transplantation
, vol.65
, pp. 1047-1053
-
-
Ontañón, J.1
Muro, M.2
García-Alonso, A.M.3
Minguela, A.4
Torio, A.5
Bermejo, J.6
Pons, J.A.7
Campos, M.8
Álvarez-López, M.R.9
-
71
-
-
33644926711
-
Study of Fas (CD95) and FasL (CD178) polymorphism in liver transplant recipients
-
Marin, L; Muro, M; Moya-Quiles, MR; Miras, M; Minguela, A; Bermejo, J; Sánchez-Bueno, F; Parrilla, P; Álvarez-López, MR. Study of Fas (CD95) and FasL (CD178) polymorphism in liver transplant recipients. Tissue Antigens, 2006, 67, 117-126.
-
(2006)
Tissue Antigens
, vol.67
, pp. 117-126
-
-
Marin, L.1
Muro, M.2
Moya-Quiles, M.R.3
Miras, M.4
Minguela, A.5
Bermejo, J.6
Sánchez-Bueno, F.7
Parrilla, P.8
Álvarez-López, M.R.9
-
72
-
-
36349002515
-
HBV and HCV Infections and Acute Rejection Differentially modulate CD95 and CD28 expression on peripheral blood lymphocytes after liver transplantation
-
Minguela, A; Miras, M; Bermejo, J; Sánchez-Bueno, F; López-Alvarez, R; MoyaQuiles, MR; Muro, M; Ontañón, J; Garcia-Alonso, AM; Parrilla, P; Alvarez-López, MR. HBV and HCV Infections and Acute Rejection Differentially modulate CD95 and CD28 expression on peripheral blood lymphocytes after liver transplantation. Human Immunol, 2006, 67, 884-893.
-
(2006)
Human Immunol
, vol.67
, pp. 884-893
-
-
Minguela, A.1
Miras, M.2
Bermejo, J.3
Sánchez-Bueno, F.4
López-Alvarez, R.5
MoyaQuiles, M.R.6
Muro, M.7
Ontañón, J.8
Garcia-Alonso, A.M.9
Parrilla, P.10
Alvarez-López, M.R.11
-
73
-
-
0033936748
-
CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant
-
Minguela, A; Marin, L; Torio, A; Muro, M; García-Alonso, AM; Moya-Quiles, MR; Sánchez-Bueno, F; Parrilla, P; Alvarez-López, MR. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant. Human Immunol, 2000, 61, 658-669.
-
(2000)
Human Immunol
, vol.61
, pp. 658-669
-
-
Minguela, A.1
Marin, L.2
Torio, A.3
Muro, M.4
García-Alonso, A.M.5
Moya-Quiles, M.R.6
Sánchez-Bueno, F.7
Parrilla, P.8
Alvarez-López, M.R.9
-
74
-
-
0036226413
-
CD95 increased expression on CD3+ and CD19+ cells is related with an increased apoptosis in response to PHA on lymphocytes from liver recipients suffering acute rejection
-
Marín, L; Minguela, A; Moya-Quiles, MR; Torío, A; Muro, M; García-Alonso, AM; Sánchez-Bueno, F; Bru, M; Parrilla, P; Álvarez-López, MR. CD95 increased expression on CD3+ and CD19+ cells is related with an increased apoptosis in response to PHA on lymphocytes from liver recipients suffering acute rejection. Transplant Proc, 2002, 34, 280-282.
-
(2002)
Transplant Proc
, vol.34
, pp. 280-282
-
-
Marín, L.1
Minguela, A.2
Moya-Quiles, M.R.3
Torío, A.4
Muro, M.5
García-Alonso, A.M.6
Sánchez-Bueno, F.7
Bru, M.8
Parrilla, P.9
Álvarez-López, M.R.10
-
75
-
-
34250164612
-
The relatioship of Anti-MICA antibodies and MICA expression with heart allograft rejection
-
Suarez-Alvarez, B; López-Vazquez, A; González, MZ; Fdez-Morera, JL; Diaz-Molina, B; Blanco-Gelaz, MA; Pascual, D; Martinez-Borra, J; Muro, M; Álvarez-López, MR; López-Larrea, C. The relatioship of Anti-MICA antibodies and MICA expression with heart allograft rejection. Am J Transplant, 2007, 7, 1842-1848.
-
(2007)
Am J Transplant
, vol.7
, pp. 1842-1848
-
-
Suarez-Alvarez, B.1
López-Vazquez, A.2
González, M.Z.3
Fdez-Morera, J.L.4
Diaz-Molina, B.5
Blanco-Gelaz, M.A.6
Pascual, D.7
Martinez-Borra, J.8
Muro, M.9
Álvarez-López, M.R.10
López-Larrea, C.11
-
76
-
-
36348965337
-
CT60A/G marker of the 3-UTR of CTLA-4 gene and liver transplant
-
Muro, M; Rojas, G; Botella, C; Miras, M; Campillo, JA; Minguela, A; Sánchez-Bueno, F; Bermejo, J; Ramirez, P; Álvarez-López, MR. CT60A/G marker of the 3-UTR of CTLA-4 gene and liver transplant. Transplant Immunol, 2008, 18, 246-249.
-
(2008)
Transplant Immunol
, vol.18
, pp. 246-249
-
-
Muro, M.1
Rojas, G.2
Botella, C.3
Miras, M.4
Campillo, J.A.5
Minguela, A.6
Sánchez-Bueno, F.7
Bermejo, J.8
Ramirez, P.9
Álvarez-López, M.R.10
-
77
-
-
20144376580
-
IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice
-
Okada, E; Yamazaki, M; Tanabe, M; Takeuchi, T; Nanno, M; Oshima, S; Okamoto, R; Tsuchiya, K; Nakamura, T; Kanai, T; Hibi, T; Watanabe, M. IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice. Am J Physiol Gastrointest Liver Physiol, 2005, 288, G745-G754.
-
(2005)
Am J Physiol Gastrointest Liver Physiol
, vol.288
, pp. G745-G754
-
-
Okada, E.1
Yamazaki, M.2
Tanabe, M.3
Takeuchi, T.4
Nanno, M.5
Oshima, S.6
Okamoto, R.7
Tsuchiya, K.8
Nakamura, T.9
Kanai, T.10
Hibi, T.11
Watanabe, M.12
-
78
-
-
33645824349
-
Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L-effector memory T cells
-
Kanai, T; Tanimoto, K; Nemoto, Y; Fujii, R; Makita, S; Totsuka, T; Watanabe, M. Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L-effector memory T cells. Am J Physiol Gastrointest Liver Physiol, 2006, 290, G1051-G1058.
-
(2006)
Am J Physiol Gastrointest Liver Physiol
, vol.290
, pp. G1051-G1058
-
-
Kanai, T.1
Tanimoto, K.2
Nemoto, Y.3
Fujii, R.4
Makita, S.5
Totsuka, T.6
Watanabe, M.7
-
79
-
-
33745275219
-
Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity
-
Holmen, N; Lundgren, A; Lundin, S; Bergin, AM; Rudin, A; Sjovall, H; Ohman, L. Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis, 2006, 12, 447-456.
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 447-456
-
-
Holmen, N.1
Lundgren, A.2
Lundin, S.3
Bergin, A.M.4
Rudin, A.5
Sjovall, H.6
Ohman, L.7
-
80
-
-
17844363998
-
Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease
-
Brimnes, J; Allez, M; Dotan, I; Shao, L; Nakazawa, A; Mayer, L. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol, 2005, 174, 5814-5822.
-
(2005)
J Immunol
, vol.174
, pp. 5814-5822
-
-
Brimnes, J.1
Allez, M.2
Dotan, I.3
Shao, L.4
Nakazawa, A.5
Mayer, L.6
-
81
-
-
33644756429
-
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn’s disease: A randomized, double-blind, placebo-controlled trial
-
Schreiber, S; Feagan, B; D’Haens, G; Colombel, JF; Geboes, K; Yurcov, M; Isakov, V; Golovenko, O; Bernstein, CN; Ludwig, D; Winter, T; Meier, U; Yong, C; Steffgen, J. Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn’s disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol, 2006, 4, 325-334.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 325-334
-
-
Schreiber, S.1
Feagan, B.2
D’Haens, G.3
Colombel, J.F.4
Geboes, K.5
Yurcov, M.6
Isakov, V.7
Golovenko, O.8
Bernstein, C.N.9
Ludwig, D.10
Winter, T.11
Meier, U.12
Yong, C.13
Steffgen, J.14
-
82
-
-
0037018761
-
Maintenance infliximab for Crohn’s disease: The ACCENT I randomised trial
-
Hanauer, SB; Feagan, BG; Lichtenstein, GR; Mayer, LF; Schreiber, S; Colombel, JF; Rachmilewitz, D; Wolf, DC; Olson, A; Bao, W; Rutgeerts, P. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet, 2002, 359, 1541-1549.
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
Rachmilewitz, D.7
Wolf, D.C.8
Olson, A.9
Bao, W.10
Rutgeerts, P.11
-
83
-
-
32044451548
-
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: The CLASSIC-I trial
-
Hanauer, SB; Sandborn, WJ; Rutgeerts, P; Fedorak, RN; Lukas, M; MacIntosh, D; Panaccione, R; Wolf, D; Pollack, P. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial. Gastroenterology, 2006, 130, 323-333.
-
(2006)
Gastroenterology
, vol.130
, pp. 323-333
-
-
Hanauer, S.B.1
Sandborn, W.J.2
Rutgeerts, P.3
Fedorak, R.N.4
Lukas, M.5
MacIntosh, D.6
Panaccione, R.7
Wolf, D.8
Pollack, P.9
-
84
-
-
11144358366
-
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease
-
Ito, H; Takazoe, M; Fukuda, Y; Hibi, T; Kusugami, K; Andoh, A; Matsumoto, T; Yamamura, T; Azuma, J; Nishimoto, N; Yoshizaki, K; Shimoyama, T; Kishimoto, T. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease. Gastroenterology, 2004, 126, 989-996.
-
(2004)
Gastroenterology
, vol.126
, pp. 989-996
-
-
Ito, H.1
Takazoe, M.2
Fukuda, Y.3
Hibi, T.4
Kusugami, K.5
Andoh, A.6
Matsumoto, T.7
Yamamura, T.8
Azuma, J.9
Nishimoto, N.10
Yoshizaki, K.11
Shimoyama, T.12
Kishimoto, T.13
-
85
-
-
0037413468
-
Natalizumab for active Crohn’s disease
-
Ghosh, S; Goldin, E; Gordon, FH; Malchow, HA; Rask-Madsen, J; Rutgeerts, P; Vyhnalek, P; Zadorova, Z; Palmer, T; Donoghue, S. Natalizumab for active Crohn’s disease. N Engl J Med, 2003, 348, 24-32.
-
(2003)
N Engl J Med
, vol.348
, pp. 24-32
-
-
Ghosh, S.1
Goldin, E.2
Gordon, F.H.3
Malchow, H.A.4
Rask-Madsen, J.5
Rutgeerts, P.6
Vyhnalek, P.7
Zadorova, Z.8
Palmer, T.9
Donoghue, S.10
-
86
-
-
0024445939
-
Pathogenesis of Crohn’s disease: Multifocal gastrointestinal infarction
-
Wakefield, AJ; Sawyerr, AM; Dhillon, AP; Pittilo, RM; Rowles, PM; Lewis, AA; Pounder, RE. Pathogenesis of Crohn’s disease: multifocal gastrointestinal infarction. Lancet, 1989, 2, 1057-1062.
-
(1989)
Lancet
, vol.2
, pp. 1057-1062
-
-
Wakefield, A.J.1
Sawyerr, A.M.2
Dhillon, A.P.3
Pittilo, R.M.4
Rowles, P.M.5
Lewis, A.A.6
Pounder, R.E.7
-
87
-
-
0025806992
-
Granulomatous vasculitis in Crohn’s disease
-
Wakefield, AJ; Sankey, EA; Dhillon, AP; Sawyerr, AM; More, L; Sim, R; Pittilo, RM; Rowles, PM; Hudson, M; Lewis, AA. Granulomatous vasculitis in Crohn’s disease. Gastroenterology, 1991, 100, 1279-1287.
-
(1991)
Gastroenterology
, vol.100
, pp. 1279-1287
-
-
Wakefield, A.J.1
Sankey, E.A.2
Dhillon, A.P.3
Sawyerr, A.M.4
More, L.5
Sim, R.6
Pittilo, R.M.7
Rowles, P.M.8
Hudson, M.9
Lewis, A.A.10
-
88
-
-
27844459466
-
Prevalence and clinical significance of sonographic detection of enlarged regional lymph nodes in Crohn’s disease
-
Maconi, G; Di Sabatino, A; Ardizzone, S; Greco, S; Colombo, E; Russo, A; Cassinotti, A; Casini, V; Corazza, GR; Bianchi Porro, G. Prevalence and clinical significance of sonographic detection of enlarged regional lymph nodes in Crohn’s disease. Scand J Gastroenterol, 2005, 40, 1328-1333.
-
(2005)
Scand J Gastroenterol
, vol.40
, pp. 1328-1333
-
-
Maconi, G.1
Di Sabatino, A.2
Ardizzone, S.3
Greco, S.4
Colombo, E.5
Russo, A.6
Cassinotti, A.7
Casini, V.8
Corazza, G.R.9
Bianchi Porro, G.10
-
89
-
-
0025819520
-
Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease
-
Miura, S; Yoshioka, M; Tanaka, S; Serizawa, H; Tashiro, H; Asakura, H; Tsuchiya, M. Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease. J Gastroenterol Hepatol 1991, 6, 49-52.
-
(1991)
J Gastroenterol Hepatol
, vol.6
, pp. 49-52
-
-
Miura, S.1
Yoshioka, M.2
Tanaka, S.3
Serizawa, H.4
Tashiro, H.5
Asakura, H.6
Tsuchiya, M.7
-
90
-
-
0038095378
-
Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column
-
Sawada, K; Muto, T; Shimoyama, T; Satomi, M, Sawada, T; Nagawa, H; Hiwatashi, N; Asakura, H; Hibi, T. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des, 2003, 9, 307-321.
-
(2003)
Curr Pharm Des
, vol.9
, pp. 307-321
-
-
Sawada, K.1
Muto, T.2
Shimoyama, T.3
Satomi, M.4
Sawada, T.5
Nagawa, H.6
Hiwatashi, N.7
Asakura, H.8
Hibi, T.9
-
91
-
-
27144476539
-
Leukocytapheresis is effective in inducing but not in maintaining remission in ulcerative colitis
-
Honma, T; Sugimura, K; Asakura, H; Matsuzawa, J; Suzuki, K; Kobayashi, M; Aoyagi, Y. Leukocytapheresis is effective in inducing but not in maintaining remission in ulcerative colitis. J Clin Gastroenterol, 2005, 39, 886-890.
-
(2005)
J Clin Gastroenterol
, vol.39
, pp. 886-890
-
-
Honma, T.1
Sugimura, K.2
Asakura, H.3
Matsuzawa, J.4
Suzuki, K.5
Kobayashi, M.6
Aoyagi, Y.7
-
92
-
-
19944429890
-
Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: An open multicenter prospective study
-
Fukuda, Y; Matsui, T; Suzuki, Y; Kanke, K; Matsumoto, T; Takazoe, M; Matsumoto, T; Motoya, S; Honma, T; Sawada, K; Yao, T; Shimoyama, T; Hibi, T. Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: an open multicenter prospective study. J Gastroenterol, 2004, 39, 1158-1164.
-
(2004)
J Gastroenterol
, vol.39
, pp. 1158-1164
-
-
Fukuda, Y.1
Matsui, T.2
Suzuki, Y.3
Kanke, K.4
Matsumoto, T.5
Takazoe, M.6
Matsumoto, T.7
Motoya, S.8
Honma, T.9
Sawada, K.10
Yao, T.11
Shimoyama, T.12
Hibi, T.13
-
93
-
-
34249333049
-
Comparative Study of Eosinophil Chemotaxis, Adhesion, and Degranulation In Vitro in Ulcerative Colitis and Crohn’s Disease
-
Coppi, LC; Thomazzi, SM; Ayrizono, ML; Coy, C; Fagundes, JJ; Juvenal, R; Goes, N; Franchi, GC; Nowill, AE; Montes, CG; Antunes, E; Geraldo, E; Ferraz, MD. Comparative Study of Eosinophil Chemotaxis, Adhesion, and Degranulation In Vitro in Ulcerative Colitis and Crohn’s Disease. Inflam Bowel Dis, 2007, 13, 211-218.
-
(2007)
Inflam Bowel Dis
, vol.13
, pp. 211-218
-
-
Coppi, L.C.1
Thomazzi, S.M.2
Ayrizono, M.L.3
Coy, C.4
Fagundes, J.J.5
Juvenal, R.6
Goes, N.7
Franchi, G.C.8
Nowill, A.E.9
Montes, C.G.10
Antunes, E.11
Geraldo, E.12
Ferraz, M.D.13
-
94
-
-
0027180157
-
Increased fecal eosinophil cationic protein in inflammatory bowel disease
-
Berstad, A; Borkje, B; Riedel, B, et al. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepato-Gastroenterol, 1993, 40, 276-278.
-
(1993)
Hepato-Gastroenterol
, vol.40
, pp. 276-278
-
-
Berstad, A.1
Borkje, B.2
Riedel, B.3
-
95
-
-
0031409459
-
Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease
-
Levy, AM; Gleich, GJ; Sandborn, WJ, et al. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc, 1997, 72, 117-123.
-
(1997)
Mayo Clin Proc
, vol.72
, pp. 117-123
-
-
Levy, A.M.1
Gleich, G.J.2
Sandborn, W.J.3
-
96
-
-
0031895124
-
Eosinophil activation in ulcerative colitis. Studies on mucosal release and localization of eosinophil granule constituents
-
Raab, Y; Fredens, K; Gerdin, B, et al. Eosinophil activation in ulcerative colitis. Studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci, 1998, 43, 1061-1070.
-
(1998)
Dig Dis Sci
, vol.43
, pp. 1061-1070
-
-
Raab, Y.1
Fredens, K.2
Gerdin, B.3
-
98
-
-
43549120052
-
Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours
-
Wedemeyer, J; Vosskuhl, K. Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours. Best Pract Res Clin Gastroenterol, 2008, 22, 537-549.
-
(2008)
Best Pract Res Clin Gastroenterol
, vol.22
, pp. 537-549
-
-
Wedemeyer, J.1
Vosskuhl, K.2
-
99
-
-
28444463001
-
Adacolumn for selective leukocytapheresis as a nonpharmacological treatment for patients with disorders of the immune system: An adjunct or an alternative to drug therapy?
-
Saniabadi, AR; Hanai, H; Suzuki, Y; Ohmori, T; Sawada Yoshimura, N; Saito, Y; Takeda, Y; Umemura, K; Kondo, K; Ikeda, Y; Fukunaga, K; Nakashima, M; Beretta, A; Bjarnason, I; Lofberg, R. Adacolumn for selective leukocytapheresis as a nonpharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? J Clin Apher, 2005, 20, 171-184.
-
(2005)
J Clin Apher
, vol.20
, pp. 171-184
-
-
Saniabadi, A.R.1
Hanai, H.2
Suzuki, Y.3
Ohmori, T.S.4
Sawada Yoshimura, N.5
Saito, Y.6
Takeda, Y.7
Umemura, K.8
Kondo, K.9
Ikeda, Y.10
Fukunaga, K.11
Nakashima, M.12
Beretta, A.13
Bjarnason, I.14
Lofberg, R.15
-
100
-
-
0028943866
-
Human neutrophil Fc receptor-mediated adhesion under flow: A hollow fibre model of intravascular arrest
-
D’Arrigo, C; Candal-Couto, JJ; Greer, M; Veale, DJ; Woof, JM. Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrest. Clin Exp Immunol, 1995, 100, 173-179.
-
(1995)
Clin Exp Immunol
, vol.100
, pp. 173-179
-
-
D’Arrigo, C.1
Candal-Couto, J.J.2
Greer, M.3
Veale, D.J.4
Woof, J.M.5
-
101
-
-
0037810900
-
Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: An in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis
-
Hiraishi, K; Takeda, Y; Shiobara, N; Shibusawa, H; Jimma, F; Kashiwagi, N; Saniabadi, AR; Adachi, M. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial, 2003, 7, 334-340.
-
(2003)
Ther Apher Dial
, vol.7
, pp. 334-340
-
-
Hiraishi, K.1
Takeda, Y.2
Shiobara, N.3
Shibusawa, H.4
Jimma, F.5
Kashiwagi, N.6
Saniabadi, A.R.7
Adachi, M.8
-
102
-
-
2942741259
-
Selective granulocyte and monocyte adsorptive apheresis as a first line treatment for steroid naive patients with active ulcerative colitis: A prospective uncontrolled study
-
Suzuki, Y; Yoshimura, N; Saniabadi, AR; Saito, Y. Selective granulocyte and monocyte adsorptive apheresis as a first line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci, 2004, 49, 565-571.
-
(2004)
Dig Dis Sci
, vol.49
, pp. 565-571
-
-
Suzuki, Y.1
Yoshimura, N.2
Saniabadi, A.R.3
Saito, Y.4
-
103
-
-
11144304095
-
Treating ulcerative colitis without medications-“look mom, no drugs!"
-
Cohen, RD. Treating ulcerative colitis without medications-“look mom, no drugs!". Gastroenterology, 2005, 128, 235-236.
-
(2005)
Gastroenterology
, vol.128
, pp. 235-236
-
-
Cohen, R.D.1
-
104
-
-
30544454919
-
Evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis
-
Kanke, K; Nakano, M; Hiraishi, H; Terano, A. Evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Dig Liv Dis, 2004, 36, 512-518.
-
(2004)
Dig Liv Dis
, vol.36
, pp. 512-518
-
-
Kanke, K.1
Nakano, M.2
Hiraishi, H.3
Terano, A.4
-
105
-
-
2442576094
-
Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or-dependent ulcerative colitis
-
Naganuma, M; Funakoshi, S; Sakuraba, A; Takagi, H; Inoue, N; Ogata, H; Iwao, Y; Ishi, H; Hibi, T. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or-dependent ulcerative colitis. Inflamm Bowel Dis, 2004, 10, 251-257.
-
(2004)
Inflamm Bowel Dis
, vol.10
, pp. 251-257
-
-
Naganuma, M.1
Funakoshi, S.2
Sakuraba, A.3
Takagi, H.4
Inoue, N.5
Ogata, H.6
Iwao, Y.7
Ishi, H.8
Hibi, T.9
-
106
-
-
4844231152
-
Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: A prospective, pilot study
-
Yamamoto, T; Umegae, S; Kitagawa, T; Yasuda, Y; Yamada, Y; Takahashi, D; Mukumoto, M; Nishimura, N; Yasue, K; Matsumoto, K. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Aliment Pharmacol Ther, 2004, 20, 783-792.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 783-792
-
-
Yamamoto, T.1
Umegae, S.2
Kitagawa, T.3
Yasuda, Y.4
Yamada, Y.5
Takahashi, D.6
Mukumoto, M.7
Nishimura, N.8
Yasue, K.9
Matsumoto, K.10
-
107
-
-
4444299017
-
Granulocyte, macrophage, monocyte apheresis for refractory ulcerative proctitis
-
Premchand, P; Takeuchi, K; Bjarnason, I. Granulocyte, macrophage, monocyte apheresis for refractory ulcerative proctitis. Eur J Gastroenterol Hepatol, 2004, 16, 943-945.
-
(2004)
Eur J Gastroenterol Hepatol
, vol.16
, pp. 943-945
-
-
Premchand, P.1
Takeuchi, K.2
Bjarnason, I.3
-
108
-
-
19944425563
-
Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: A prospective, open, pilot study
-
Domenech, E; Hinojosa, J; Esteve-Comas, M; Gomollon, F; Herrera, JM; Bastida, G; Obrador, A; Ruiz, R; Saro, C; Gassull, MA. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther, 2004, 20, 1347-1352.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 1347-1352
-
-
Domenech, E.1
Hinojosa, J.2
Esteve-Comas, M.3
Gomollon, F.4
Herrera, J.M.5
Bastida, G.6
Obrador, A.7
Ruiz, R.8
Saro, C.9
Gassull, M.A.10
-
109
-
-
0037285976
-
Granulocytapheresis for Crohn’s disease: A report on seven refractory patients
-
Matsui, T; Nishimura, T; Matake, H; Ohta, T; Sakurai, T; Yao, T. Granulocytapheresis for Crohn’s disease: a report on seven refractory patients. Am J Gastroenterol, 2003, 98, 511-512.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 511-512
-
-
Matsui, T.1
Nishimura, T.2
Matake, H.3
Ohta, T.4
Sakurai, T.5
Yao, T.6
-
110
-
-
19944429890
-
Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: An open multicenter prospective study
-
Fukuda, Y; Matsui, T; Suzuki, Y; Kanke, K; Matsumoto, T; Takazoe, M; Matsumoto, T; Motoya, S; Honma, T; Sawada, K; Yao, T; Shimoyama, T; Hibi, T. Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: an open multicenter prospective study. J Gastroenterol, 2004, 39, 1158-1164.
-
(2004)
J Gastroenterol
, vol.39
, pp. 1158-1164
-
-
Fukuda, Y.1
Matsui, T.2
Suzuki, Y.3
Kanke, K.4
Matsumoto, T.5
Takazoe, M.6
Matsumoto, T.7
Motoya, S.8
Honma, T.9
Sawada, K.10
Yao, T.11
Shimoyama, T.12
Hibi, T.13
-
111
-
-
4444274915
-
Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis
-
Hanai, H; Watanabe, F; Yamada, M; Sato, Y; Takeuchi, K; Iida, T; Tozawa, K; Tanaka, T; Maruyama, Y; Matsushita, I; Iwaoka, Y; Kikuch, K; Saniabadi, AR. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion, 2004, 70, 36-44.
-
(2004)
Digestion
, vol.70
, pp. 36-44
-
-
Hanai, H.1
Watanabe, F.2
Yamada, M.3
Sato, Y.4
Takeuchi, K.5
Iida, T.6
Tozawa, K.7
Tanaka, T.8
Maruyama, Y.9
Matsushita, I.10
Iwaoka, Y.11
Kikuch, K.12
Saniabadi, A.R.13
-
112
-
-
31144469458
-
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis
-
Kruis, W; Dignass, A; Steinhagen-Thiessen, E; Morgenstern, J; Mossner, J; Schreiber, S; Vecchi, M; Malesci, A; Reinshagen, M; Lofberg, R. Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis. World J Gastroenterol, 2005, 11, 7001-7006.
-
(2005)
World J Gastroenterol
, vol.11
, pp. 7001-7006
-
-
Kruis, W.1
Dignass, A.2
Steinhagen-Thiessen, E.3
Morgenstern, J.4
Mossner, J.5
Schreiber, S.6
Vecchi, M.7
Malesci, A.8
Reinshagen, M.9
Lofberg, R.10
-
113
-
-
33751538077
-
A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis
-
Suzuki, Y; Yoshimura, N; Saito, Y; Saniabadi, A. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci, 2006, 51, 2031-2038.
-
(2006)
Dig Dis Sci
, vol.51
, pp. 2031-2038
-
-
Suzuki, Y.1
Yoshimura, N.2
Saito, Y.3
Saniabadi, A.4
-
114
-
-
33845971251
-
Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis
-
Hanai, H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol, 2006, 12, 7568-7577.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 7568-7577
-
-
Hanai, H.1
-
115
-
-
33745323236
-
Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis
-
Hanai, H; Iida, T; Yamada, M; Sato, Y; Takeuchi, K; Tanaka, T; Kondo, K; Kikuyama, M; Maruyama, Y; Iwaoka, Y; Nakamura, A; Hirayama, K; Saniabadi, AR; Watanabe, F. Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis. World J Gastroenterol, 2006, 12, 3393-3399.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 3393-3399
-
-
Hanai, H.1
Iida, T.2
Yamada, M.3
Sato, Y.4
Takeuchi, K.5
Tanaka, T.6
Kondo, K.7
Kikuyama, M.8
Maruyama, Y.9
Iwaoka, Y.10
Nakamura, A.11
Hirayama, K.12
Saniabadi, A.R.13
Watanabe, F.14
-
116
-
-
33646540632
-
Adacolumn apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse (abstract)
-
Maiden, L; Baur, R; Takeuchi, K; Bjarnason, I. Adacolumn apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse (abstract). Gut, 2005, 54 (suppl NOVII): A57.
-
(2005)
Gut
, vol.54
, pp. A57
-
-
Maiden, L.1
Baur, R.2
Takeuchi, K.3
Bjarnason, I.4
-
117
-
-
0031903013
-
Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation
-
Nikolaus, S; Bauditz, J; Gionchetti, P; Witt, C; Lochs, H; Schreiber, S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut, 1998, 42, 470-476.
-
(1998)
Gut
, vol.42
, pp. 470-476
-
-
Nikolaus, S.1
Bauditz, J.2
Gionchetti, P.3
Witt, C.4
Lochs, H.5
Schreiber, S.6
-
118
-
-
0034234796
-
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
-
Tibble, JA; Sigthorsson, G; Bridger, S; Fagerhol, MK; Bjarnason, I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology, 2000, 119, 15-22.
-
(2000)
Gastroenterology
, vol.119
, pp. 15-22
-
-
Tibble, J.A.1
Sigthorsson, G.2
Bridger, S.3
Fagerhol, M.K.4
Bjarnason, I.5
-
119
-
-
0033784967
-
Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy
-
Limburg, PJ; Ahlquist, DA; Sandborn, WJ; Mahoney, DW; Devens, ME; Harrington, JJ; Zinsmeister, AR. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol, 2000, 95, 2831-2837.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 2831-2837
-
-
Limburg, P.J.1
Ahlquist, D.A.2
Sandborn, W.J.3
Mahoney, D.W.4
Devens, M.E.5
Harrington, J.J.6
Zinsmeister, A.R.7
-
120
-
-
0033013167
-
Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease
-
Roseth, AG; Schmidt, PN; Fagerhol, MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol, 1999, 34, 50-54.
-
(1999)
Scand J Gastroenterol
, vol.34
, pp. 50-54
-
-
Roseth, A.G.1
Schmidt, P.N.2
Fagerhol, M.K.3
-
121
-
-
0028894398
-
The production of cytokines by polymorphonuclear neutrophils
-
Cassatella, MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today, 1995, 16, 21-26.
-
(1995)
Immunol Today
, vol.16
, pp. 21-26
-
-
Cassatella, M.A.1
-
122
-
-
33747399413
-
Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: Cytokine profiles and endoscopic findings
-
Yamamoto, T; Saniabadi, AR; Umegae, S; Matsumoto, K. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings. Inflamm Bowel Dis, 2006, 12, 719-726.
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 719-726
-
-
Yamamoto, T.1
Saniabadi, A.R.2
Umegae, S.3
Matsumoto, K.4
-
123
-
-
4444250166
-
Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis
-
Hanai, H; Watanabe, F; Yamada, M; Sato, Y; Takeuchi, K; Iida, T; Tozawa, K; Tanaka, T; Maruyama, Y; Matsushita, I; Iwaoka, Y; Saniabadi, A. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis. Am J Gastroenterol, 2004, 99, 1532-1538.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 1532-1538
-
-
Hanai, H.1
Watanabe, F.2
Yamada, M.3
Sato, Y.4
Takeuchi, K.5
Iida, T.6
Tozawa, K.7
Tanaka, T.8
Maruyama, Y.9
Matsushita, I.10
Iwaoka, Y.11
Saniabadi, A.12
-
124
-
-
33646571241
-
The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease
-
Kanai, T; Hibi, T; Watanabe, M. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opin Biol Ther, 2006, 6, 453-466.
-
(2006)
Expert Opin Biol Ther
, vol.6
, pp. 453-466
-
-
Kanai, T.1
Hibi, T.2
Watanabe, M.3
-
125
-
-
0035036047
-
Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter study
-
Shimoyama, T; Sawada, K; Hiwatashi, N; Sawada, T; Matsueda, K; Munakata, A; Asakura, H; Tanaka, T; Kasukawa, R; Kimura, K; Suzuki, Y; Nagamachi, Y; Muto, T; Nagawa, H; Iizuka, B; Baba, S; Nasu, M; Kataoka, T, Kashiwagi, N; Saniabadi, AR. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher, 2001, 16, 1-9.
-
(2001)
J Clin Apher
, vol.16
, pp. 1-9
-
-
Shimoyama, T.1
Sawada, K.2
Hiwatashi, N.3
Sawada, T.4
Matsueda, K.5
Munakata, A.6
Asakura, H.7
Tanaka, T.8
Kasukawa, R.9
Kimura, K.10
Suzuki, Y.11
Nagamachi, Y.12
Muto, T.13
Nagawa, H.14
Iizuka, B.15
Baba, S.16
Nasu, M.17
Kataoka, T.18
Kashiwagi, N.19
Saniabadi, A.R.20
more..
-
126
-
-
0027198002
-
Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
-
Mohler, KM; Torrance, DS; Smith, CA; Goodwin, RG; Stremler, KE, Fung, VP; Madani, H; Widmer, MB. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol, 1993, 151, 1548-1561.
-
(1993)
J Immunol
, vol.151
, pp. 1548-1561
-
-
Mohler, K.M.1
Torrance, D.S.2
Smith, C.A.3
Goodwin, R.G.4
Stremler, K.E.5
Fung, V.P.6
Madani, H.7
Widmer, M.B.8
-
127
-
-
0031835846
-
A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis
-
Kashiwagi, N; Hirata, I; Kasukawa, R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher, 1998, 2, 134-141.
-
(1998)
Ther Apher
, vol.2
, pp. 134-141
-
-
Kashiwagi, N.1
Hirata, I.2
Kasukawa, R.3
-
128
-
-
0036270464
-
Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis
-
Kashiwagi, N; Sugimura, K; Koiwai, H; Yamamoto, H; Yoshikawa, T; Saniabadi, AR; Adachi, M; Shimoyama, T. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci, 2002, 47, 1334-1341.
-
(2002)
Dig Dis Sci
, vol.47
, pp. 1334-1341
-
-
Kashiwagi, N.1
Sugimura, K.2
Koiwai, H.3
Yamamoto, H.4
Yoshikawa, T.5
Saniabadi, A.R.6
Adachi, M.7
Shimoyama, T.8
-
129
-
-
3242745879
-
Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: Evidence for the involvement of plasma IgG, complement C3 and beta2 integrin
-
Takeda, Y; Shiobara, N; Saniabadi, AR; Adachi, M; Hiraishi, K. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin. Inflamm Res, 2004, 53, 277-283.
-
(2004)
Inflamm Res
, vol.53
, pp. 277-283
-
-
Takeda, Y.1
Shiobara, N.2
Saniabadi, A.R.3
Adachi, M.4
Hiraishi, K.5
-
130
-
-
0031861940
-
Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD)
-
Dionne, S; D’Agata, ID; Hiscott, J; Vanounou, T; Seidman, EG. Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin Exp Immunol, 1998, 112, 435-442.
-
(1998)
Clin Exp Immunol
, vol.112
, pp. 435-442
-
-
Dionne, S.1
D’Agata, I.D.2
Hiscott, J.3
Vanounou, T.4
Seidman, E.G.5
-
131
-
-
0026056197
-
Blocking IL-1: Interleukin 1 receptor antagonist in vivo and in vitro
-
Dinarello, CA; Thompson, RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today, 1991, 12, 404-410.
-
(1991)
Immunol Today
, vol.12
, pp. 404-410
-
-
Dinarello, C.A.1
Thompson, R.C.2
-
132
-
-
43549094970
-
Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocyte in inflammatory bowel disease
-
Hanai, H; Iida, T; Takeuchi, K; Watanabe, F; Yamada, M; Kikuyama, M; Maruyama, Y; Iwaoka, Y; Hirayama, K; Nagata, S; Takai, K. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocyte in inflammatory bowel disease. Am J Gastroenterol, 2008, 103, 1210-1216.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 1210-1216
-
-
Hanai, H.1
Iida, T.2
Takeuchi, K.3
Watanabe, F.4
Yamada, M.5
Kikuyama, M.6
Maruyama, Y.7
Iwaoka, Y.8
Hirayama, K.9
Nagata, S.10
Takai, K.11
-
133
-
-
62149090337
-
Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy
-
Hanai, H. Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy. Eur J Gastroenterol Hepatol, 2008, 20, 596-600.
-
(2008)
Eur J Gastroenterol Hepatol
, vol.20
, pp. 596-600
-
-
Hanai, H.1
-
134
-
-
31844441031
-
Serologic Markers in Inflammatory Bowel Disease
-
Bossuit, X. Serologic Markers in Inflammatory Bowel Disease. Clin Chemistry, 2006, 52, 171-181.
-
(2006)
Clin Chemistry
, vol.52
, pp. 171-181
-
-
Bossuit, X.1
-
135
-
-
34249863151
-
Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicenter study
-
Desplat-Jégo, S; Johanet, C; Escande, A; Goetz, J; Fabien, N; Olsson, N; Ballot, E; Sarles, J; Baudon, JJ; Grimaud, JC; Veyrac, M; Chamouard, P; Humbel, RL. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicenter study. World J Gastroenterol, 2007, 13, 2312-2318.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 2312-2318
-
-
Desplat-Jégo, S.1
Johanet, C.2
Escande, A.3
Goetz, J.4
Fabien, N.5
Olsson, N.6
Ballot, E.7
Sarles, J.8
Baudon, J.J.9
Grimaud, J.C.10
Veyrac, M.11
Chamouard, P.12
Humbel, R.L.13
-
136
-
-
15644376138
-
Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats
-
Natsui, M; Kawasaki, K; Takizawa, H; Hayashi, SI; Matsuda, Y; Sugimura, K; Seki, K; Narisawa, R; Sendo, F; Asakura, H. Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats. J Gastroenterol Hepatol, 1997, 12, 801-808.
-
(1997)
J Gastroenterol Hepatol
, vol.12
, pp. 801-808
-
-
Natsui, M.1
Kawasaki, K.2
Takizawa, H.3
Hayashi, S.I.4
Matsuda, Y.5
Sugimura, K.6
Seki, K.7
Narisawa, R.8
Sendo, F.9
Asakura, H.10
-
137
-
-
0031718221
-
Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn’s disease
-
Arai, F; Takahashi, T; Furukawa, K; Matsushima, K; Asakura, H. Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn’s disease. Dig Dis Sci, 1998, 43, 2071-2079.
-
(1998)
Dig Dis Sci
, vol.43
, pp. 2071-2079
-
-
Arai, F.1
Takahashi, T.2
Furukawa, K.3
Matsushima, K.4
Asakura, H.5
-
138
-
-
0032014268
-
Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis
-
Anezaki, K; Asakura, H; Honma, T; Ishizuka, K; Funakoshi, K; Tsukada, Y; Narisawa, R. Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis. Intern Med, 1998, 37, 253-258.
-
(1998)
Intern Med
, vol.37
, pp. 253-258
-
-
Anezaki, K.1
Asakura, H.2
Honma, T.3
Ishizuka, K.4
Funakoshi, K.5
Tsukada, Y.6
Narisawa, R.7
-
139
-
-
33344466383
-
Defective acute inflammation in Crohn’s disease: A clinical investigation
-
Marks, DJ; Harbord, MW; MacAllister, R; Rahman, FZ; Young, J; Al-Lazikani, B; Lees, W; Novelli, M; Bloom, S; Segal, AW. Defective acute inflammation in Crohn’s disease: a clinical investigation. Lancet, 2006, 367, 668-678.
-
(2006)
Lancet
, vol.367
, pp. 668-678
-
-
Marks, D.J.1
Harbord, M.W.2
MacAllister, R.3
Rahman, F.Z.4
Young, J.5
Al-Lazikani, B.6
Lees, W.7
Novelli, M.8
Bloom, S.9
Segal, A.W.10
-
140
-
-
0023713281
-
Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn’s disease
-
Kitahora, T; Suzuki, K; Asakura, H; Yoshida, T; Suematsu, M; Watanabe, M; Aiso, S; Tsuchiya, M. Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn’s disease. Dig Dis Sci, 1988, 33, 951-955.
-
(1988)
Dig Dis Sci
, vol.33
, pp. 951-955
-
-
Kitahora, T.1
Suzuki, K.2
Asakura, H.3
Yoshida, T.4
Suematsu, M.5
Watanabe, M.6
Aiso, S.7
Tsuchiya, M.8
-
141
-
-
17944370715
-
Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes
-
Sugimura, K; Hasegawa, K; Yoshida, K; Suzuki, A; Ishizuka, K; Ohtsuka, K; Honma, T; Narisawa, R; Asakura, H. Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand J Gastroenterol, 2001, 36, 1301-1306.
-
(2001)
Scand J Gastroenterol
, vol.36
, pp. 1301-1306
-
-
Sugimura, K.1
Hasegawa, K.2
Yoshida, K.3
Suzuki, A.4
Ishizuka, K.5
Ohtsuka, K.6
Honma, T.7
Narisawa, R.8
Asakura, H.9
-
142
-
-
33744812402
-
Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-delta pathway activation
-
Song, J; Li, J; Lulla, A; Evers, BM; Chung, DH. Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-delta pathway activation. Am J Physiol Cell Physiol, 2006, 290, C1469-C1476.
-
(2006)
Am J Physiol Cell Physiol
, vol.290
, pp. C1469-C1476
-
-
Song, J.1
Li, J.2
Lulla, A.3
Evers, B.M.4
Chung, D.H.5
-
143
-
-
34249805957
-
Lecithinized superoxide dismutase was effective for ulcerative colitis
-
Mizushima, T. Lecithinized superoxide dismutase was effective for ulcerative colitis. Inflam Regen, 2006, 26, 317.
-
(2006)
Inflam Regen
, vol.26
, pp. 317
-
-
Mizushima, T.1
-
144
-
-
0035158627
-
Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: Divergent roles of superoxide and nitric oxide
-
Krieglstein, CF; Cerwinka, WH; Laroux, FS; Salter, JW; Russell, JM; Schuermann, G; Grisham, MB; Ross, CR; Granger, DN. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med, 2001, 194, 1207-1218.
-
(2001)
J Exp Med
, vol.194
, pp. 1207-1218
-
-
Krieglstein, C.F.1
Cerwinka, W.H.2
Laroux, F.S.3
Salter, J.W.4
Russell, J.M.5
Schuermann, G.6
Grisham, M.B.7
Ross, C.R.8
Granger, D.N.9
-
145
-
-
0141534421
-
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients
-
Danese, S; Katz, JA; Saibeni, S; Papa, A; Gasbarrini, A; Vecchi, M; Fiocchi, C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut, 2003, 52, 1435-1441.
-
(2003)
Gut
, vol.52
, pp. 1435-1441
-
-
Danese, S.1
Katz, J.A.2
Saibeni, S.3
Papa, A.4
Gasbarrini, A.5
Vecchi, M.6
Fiocchi, C.7
-
146
-
-
33744510694
-
Angiogenesis as a novel component of inflammatory bowel disease pathogenesis
-
Danese, S; Sans, M; de la Motte, C; Graziani, C; West, G; Phillips, MH; Pola, R; Rutella, S; Willis, J; Gasbarrini, A; Fiocchi, C. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology, 2006, 130, 2060-2073.
-
(2006)
Gastroenterology
, vol.130
, pp. 2060-2073
-
-
Danese, S.1
Sans, M.2
de la Motte, C.3
Graziani, C.4
West, G.5
Phillips, M.H.6
Pola, R.7
Rutella, S.8
Willis, J.9
Gasbarrini, A.10
Fiocchi, C.11
-
147
-
-
18544383322
-
Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract
-
Okamoto, R; Yajima, T; Yamazaki, M; Kanai, T; Mukai, M; Okamoto, S; Ikeda, Y; Hibi, T; Inazawa, J; Watanabe, M. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med, 2002, 8, 1011-1017.
-
(2002)
Nat Med
, vol.8
, pp. 1011-1017
-
-
Okamoto, R.1
Yajima, T.2
Yamazaki, M.3
Kanai, T.4
Mukai, M.5
Okamoto, S.6
Ikeda, Y.7
Hibi, T.8
Inazawa, J.9
Watanabe, M.10
-
148
-
-
20444473689
-
A regenerative role for bone marrow following experimental colitis: Contribution to neovasculogenesis and myofibroblasts
-
Brittan, M; Chance, V; Elia, G; Poulsom, R; Alison, MR; MacDonald, TT; Wright, NA. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology, 2005, 128, 1984-1995.
-
(2005)
Gastroenterology
, vol.128
, pp. 1984-1995
-
-
Brittan, M.1
Chance, V.2
Elia, G.3
Poulsom, R.4
Alison, M.R.5
MacDonald, T.T.6
Wright, N.A.7
-
149
-
-
0031889085
-
Course of Crohn’s disease after allogeneic marrow transplantation
-
Lopez-Cubero, SO; Sullivan, KM; McDonald, GB. Course of Crohn’s disease after allogeneic marrow transplantation. Gastroenterology, 1998, 114, 433-440.
-
(1998)
Gastroenterology
, vol.114
, pp. 433-440
-
-
Lopez-Cubero, S.O.1
Sullivan, K.M.2
McDonald, G.B.3
-
150
-
-
38549087476
-
Innate immunity in inflammatory bowel disease: A disease hypothesis
-
Marks, DJB; Segal, AW. Innate immunity in inflammatory bowel disease: a disease hypothesis. J Pathol, 2008, 214, 260-266.
-
(2008)
J Pathol
, vol.214
, pp. 260-266
-
-
Marks, D.J.B.1
Segal, A.W.2
-
151
-
-
34548156973
-
Late-Breaking News from the-4th International Meeting on Inflammatory Bowel Diseases Capri, 2006
-
Latella, G; Fiocchi, C; Caprilli, R. Late-Breaking News from the-4th International Meeting on Inflammatory Bowel Diseases Capri, 2006. Inflamm Bowel Dis, 2007, 13, 1031-1050.
-
(2007)
Inflamm Bowel Dis
, vol.13
, pp. 1031-1050
-
-
Latella, G.1
Fiocchi, C.2
Caprilli, R.3
-
152
-
-
33751549013
-
Suppression of experimental colitis by intestinal mononuclear phagocytes
-
Qualls, JE; Kaplan, AM; van Rooijen, N; Cohen, DA. Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukocyte Biol, 2006, 80, 802-815.
-
(2006)
J Leukocyte Biol
, vol.80
, pp. 802-815
-
-
Qualls, J.E.1
Kaplan, A.M.2
van Rooijen, N.3
Cohen, D.A.4
-
153
-
-
35648937573
-
Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease
-
Kawada, M; Arihiro, A; Mizoguchi, E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol, 2007, 13, 5581-5593.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 5581-5593
-
-
Kawada, M.1
Arihiro, A.2
Mizoguchi, E.3
-
154
-
-
35649000421
-
Role of bacteria in the etiopathogenesis of inflammatory bowel disease
-
Barnich, N; Darfeuilli-Michaud, A. Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol, 2007, 13, 5571-5576.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 5571-5576
-
-
Barnich, N.1
Darfeuilli-Michaud, A.2
|